2026 ICD-10-CM Diagnosis Code E70.30Albinism, unspecified
ICD-10-CM Codes›E00–E89›E70-E88›E70
- Billable — Valid for Submission
- Chronic Condition
E70.30 is a billable ICD-10-CM diagnosis code for albinism, unspecified. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026). Coders also document this condition as albinism. In AHRQ's Clinical Classifications Software (CCSR), this diagnosis falls under Other specified and unspecified nutritional and metabolic disorders.
Code Identity
Code Classification
Approximate SynonymsGuidance
Alternate terms and clinical phrases that map to this code.
- Albinism
- Albinism with deafness syndrome
- Microcephalus with albinism and digital anomaly syndrome
- Neural hearing loss
- Partial albinism
Index to Diseases and InjuriesGuidance
Alphabetical index entries that point to this code.
- Albinism, albino - E70.30
- Albinismus - E70.30
External Cause of Injuries IndexGuidance
References for this code in the External Cause of Injuries Index.
- Albinism, albino
- Albinismus
Clinical ClassificationClinical
AHRQ’s CCSR groups this code into broader clinical categories.
Clinical InformationClinical
Albinism
general term for a number of inherited defects of amino acid metabolism in which there is a deficiency or absence of pigment in the eyes, skin, or hair.Albinism, Ocular
albinism affecting the eye in which pigment of the hair and skin is normal or only slightly diluted. the classic type is x-linked (nettleship-falls), but an autosomal recessive form also exists. ocular abnormalities may include reduced pigmentation of the iris, nystagmus, photophobia, strabismus, and decreased visual acuity.Albinism, Oculocutaneous
heterogeneous group of autosomal recessive disorders comprising at least four recognized types, all having in common varying degrees of hypopigmentation of the skin, hair, and eyes. the two most common are the tyrosinase-positive and tyrosinase-negative types.Piebaldism
autosomal dominant, congenital disorder characterized by localized hypomelanosis of the skin and hair. the most familiar feature is a white forelock presenting in 80 to 90 percent of the patients. the underlying defect is possibly related to the differentiation and migration of melanoblasts, as well as to defective development of the neural crest (neurocristopathy). piebaldism may be closely related to waardenburg syndrome.Waardenburg Syndrome
rare, autosomal dominant disease with variable penetrance and several known clinical types. characteristics may include depigmentation of the hair and skin, congenital deafness, heterochromia iridis, medial eyebrow hyperplasia, hypertrophy of the nasal root, and especially dystopia canthorum. the underlying cause may be defective development of the neural crest (neurocristopathy). waardenburg's syndrome may be closely related to piebaldism. klein-waardenburg syndrome refers to a disorder that also includes upper limb abnormalities.
Patient EducationClinical
Skin Pigmentation Disorders
Pigmentation means coloring. Skin pigmentation disorders affect the color of your skin. Your skin gets its color from a pigment called melanin. Special cells in the skin make melanin. When these cells become damaged or unhealthy, it affects melanin production. Some pigmentation disorders affect just patches of skin.
Read the full article at MedlinePlus
Courtesy of MedlinePlus, a service of the U.S. National Library of Medicine.
Convert E70.30 to ICD-9-CMHistory
The closest ICD-9-CM equivalents under the General Equivalence Mappings.
Code HistoryHistory
Questions About E70.30Overview
Is E70.30 (Albinism) a billable code?
Yes. This is a billable ICD-10-CM code, specific enough to report albinism, unspecified on HIPAA-covered claims from October 1, 2025 through September 30, 2026.
What is the ICD-9 equivalent of E70.30?
Under the General Equivalence Mappings, albinism, unspecified converts to ICD-9-CM 270.2 (arom amin-acid metab NEC). The mapping is approximate, so confirm the match fits the documentation.
Footnotes
[1] Chronic - a chronic condition code indicates a condition lasting 12 months or longer and its effect on the patient based on one or both of the following criteria:
- The condition results in the need for ongoing intervention with medical products,treatment, services, and special equipment
- The condition places limitations on self-care, independent living, and social interactions.
